Policy


5 Ways to Participate in the Psychedelics Boom

March 27th, 2020 - Ryan Allway

The psychedelics industry is quickly becoming the next frontier market for investors as the cannabis industry matures. Through a combination of cutting-edge research and decriminalization, investors are hoping that the industry moves in the same direction as medical cannabis over the coming years. Let’s take a look at five public companies in the space and […]

Canna World Expo Brings Together Cannabis Thought Leaders in a COVID-19 Environment

March 25th, 2020 - Ryan Allway

The Canna World Expo is a global two-day online symposium featuring more than 20 industry experts taking place on April 4 and 11, 2020. The event will bring together more than two dozen industry leaders across four continents for a live question and answer format moderated by journalists that cover the industry from several angles. […]

Cannabis Stocks Rebound, Sales Spike Amid COVID-19 Outbreak

March 20th, 2020 - Ryan Allway

Cannabis stocks have experienced a precipitous decline so far this year. The ETFMG Alternative Harvest ETF (MJ) — the largest ETF in the space with more than $600 million in assets under management — is down more than 45 percent and the AdvisorShares Pure Cannabis ETF (YOLO) — the second largest fund — is down […]

Merida’s Coronavirus Hot Take: Insight Straight from the Goniophotometer

March 20th, 2020 - Ryan Allway

The following is a guest post from Merida Capital, a private equity investment firm targeting fundamental growth drivers underpinning the rapid development of the cannabis industry. First and foremost, we hope everyone reading this is safe, healthy and takes reasonable precaution. Be concerned, be smart, and be vigilant so that you don’t contribute to the spread […]

Oregon Looks to Become the First State to Legalize Psychedelics

March 12th, 2020 - Ryan Allway

Activists in Oregon have collected more than 100,000 signatures on a measure to legalize psilocybin for therapeutic purposes across the state. The Oregon Psilocybin Society now has enough signatures to qualify for the November ballot, and once verified, voters will be able to decide on what’s effectively a medical use legalization in the new year. […]

Canadian Cannabis Sales Near $150M in December

February 24th, 2020 - Ryan Allway

Canadian retail cannabis sales rose about eight percent to $146.2 million in December 2019, according to Statistics Canada. While full-year retail sales of $1.2 billion were below expectations, the strong end to the year suggests that the industry could be on the rebound as supply chain issues are resolved and the number of retail stores […]

BDS Analytics’ CPI & Cannabis Consumer Sales Report – December 2019

February 21st, 2020 - Ryan Allway

The one-of-a-kind CPI is a benchmark of retail sales pricing across cannabis products in select legalized U.S. markets. The index currently reports sales in Arizona, California, Colorado, Nevada and Oregon— state markets that generated more than 50 percent of the legalized U.S. sales in 2018. Underlying pricing data is the compilation of actual dispensary transactions […]

Angels & VCs Start to Move into Psychedelics

February 21st, 2020 - Ryan Allway

Venture capitalists are often the first investors in emerging technologies, from cannabis to cryptocurrencies. Unlike large institutional investors, they are willing to take on high levels of risk in exchange for the potential to 10x or 100x their investments. Many VCs make most of their returns from just a handful of companies per “fund” that […]

Biggest Cannabis Investing Conference to Hit Florida Begins Next Week

February 20th, 2020 - Ryan Allway

The Benzinga Cannabis Capital Conference is an event that brings together some of the biggest voices and names in the industry. The conference is set to take place next week, Feb. 24-25, at the Fontainebleau Hotel in Miami Beach. At this event, investors can come face-to-face with top cannabis companies to hear about their advancements […]

How to Invest in Psychedelics

February 3rd, 2020 - Ryan Allway

Denver was one of the first cities in the country to legalize adult-use cannabis and its move to decriminalize psychedelics could open the door to an entirely new market. Like marijuana, advocates for magic mushrooms have had to overcome both stereotypes and excessive regulation to bring attention to its potentially significant medical benefits. Some studies […]

Golden Key 3.0 – the Hottest Party of MJBizCon Returns

December 6th, 2019 - Rachelle Gordon

This year’s MJBizCon in Las Vegas is poised to be the biggest yet. And while many of the 35,000+ attendees are excited to explore the expo floor and hear talks from some of the cannabis industry’s biggest names, everyone knows the after-parties are going to be the real talk of the town.  One event that […]

BDS Analytics’ Cannabis Retail Price Index (CPI) & Cannabis Consumer Sales Report for September 2019

November 26th, 2019 - Ryan Allway

The one-of-a-kind CPI is a benchmark of retail sales pricing across cannabis products in select legalized U.S. markets. The index currently represents sales in Arizona, California, Colorado, Nevada, and Oregon, states that generated more than 50 percent of legalized U.S. sales in 2018. Underlying pricing data is the compilation of actual dispensary transactions captured by […]

YIELD GROWTH Closes Agreement to License 126 Product Formulas to Subsidiary Flourish Mushroom Labs

November 7th, 2019 - Ryan Allway

Vancouver, British Columbia–(Newsfile Corp. – November 7, 2019) – The Yield Growth Corp. (CSE: BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that on November 6, 2019 Yield Growth closed an agreement to license 126 product formulas to subsidiary Flourish Mushroom Labs. Flourish Mushroom Labs To view an enhanced version of this graphic, please visit: https://orders.newsfilecorp.com/files/6377/49526_mushrooms.jpg […]

Cannabis Consumer Price Index: Executive Summary – August 2019 (Released October 2019)

October 9th, 2019 - Mark Collins

The one-of-a-kind Cannabis Market CPI is a benchmark of retail sales pricing across cannabis products in select legalized U.S. markets. The index currently reports sales in Arizona, California, Colorado, Nevada, and Oregon, states that generated more than 60 percent of legalized U.S. sales in 2018. Underlying pricing data is the compilation of actual dispensary transactions […]

Spotlight on Microscopes & Machines Conference: Where the Science of Cannabis Becomes Operational Reality

September 6th, 2019 - Mark Collins

Organizers from left to right Ariel Clark, Laura Albers, Alicia Wapen, Joseph Verdi and Travis Turner. (Photo: Authors Own) Microscopes & Machines is a blended cannabis and hemp medical, science, and manufacturing technology conference.  The organizers had an incredible line up in the light and airy Grass Room, a famous and historical venue in Downtown L.A. […]

Spotlight on Lift & Co. Cannabis Expo Toronto 2019

August 20th, 2019 - Mark Collins

The annual Lift & Co. Cannabis Expo Toronto is a key calendar event for global Cannabis investors and industry stakeholders. With Toronto as the hub of the Canadian finance and media industries, this event location strategically draws in pre-eminent industry leaders, business owners, thought leaders, entrepreneurs, creatives, start-ups, and consumers. Here, they come together to […]

The Evolution of the CSE in the Global Cannabis Industry

August 6th, 2019 - Ryan Allway

There’s no doubt that cannabis has been a game-changer for the Canadian capital markets. After Canada liberalized its medical program in 2012, companies immediately began approaching the Canadian Securities Exchange (CSE) to raise the capital required to build indoor greenhouses and participate in a market that they knew would continue to grow over time. In […]

Investment Banks See Tremendous Potential in Cannabis Dealflow

August 5th, 2019 - Ryan Allway

The cannabis industry is projected to reach $66.5 billion by 2025, according to Grand View Research, representing a 23.9% compound annual growth rate. In addition to Canada’s maturing industry, investors are becoming increasingly comfortable with the regulatory environment in the United States, despite the plant’s status as a Schedule I Controlled Substance on a federal […]

New CFN & Viridian Cannabis Capital Markets Wrap Discusses Key Industry and Regulatory Trends

July 22nd, 2019 - Ryan Allway

CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today announced the release of the second video episode in its CFN Media & Viridian Capital Cannabis Markets Wrap series filmed at the MJMicro Conference and featuring the President of Viridian Capital, Scott Greiper, recounting the […]

The State of New Jersey Marijuana Legalization

July 9th, 2019 - Ryan Allway

New Jersey has nearly 50,000 medical marijuana patients and out-of-state patients may legally bring their marijuana into the state for up to six months. With nearly nine million residents, the state is the 11th largest in the United States and the most densely populated state with more than 1,200 people per square mile, making it […]

Shark Tank’s Kevin O’Leary Spells Out What Institutional Investors Need from the Cannabis Industry 

June 26th, 2019 - Ryan Allway

Kevin O’Leary may be best-known for his role on ABC’s hit TV show, Shark Tank, but he also heads up O’Shares ETF Investments, which provides rules-based, quality-focused indexed ETFs for institutional investors. CFN Media recently caught up with Mr. O’Leary, better known as Mr. Wonderful, to discuss what institutional investors are looking for in the […]

Top 5 Takeaways from Bruce Linton’s Exclusive Interview with CFN Media at the NYC CWCB Expo

June 20th, 2019 - Ryan Allway

CFN Media caught up with Bruce Linton, Co-CEO of Canopy Growth Corp. (TSX: WEED) (NYSE: CGC) to discuss some of the cannabis industry’s biggest trends at the CWCB Expo in NYC in May 2019. Sign up for the CFN Newsletter using the form in the right sidebar of this page or learn more about Becoming […]

3 Cannabis Amendments That Could Be Included in the Federal Spending Bill

June 17th, 2019 - Ryan Allway

Lawmakers will consider nearly a dozen cannabis-related amendments this week as part of a large appropriations bill to fund parts of the federal government in 2020. Rep. Earl Blumenauer (D-OR) and Tom McClintock (R-CA) reintroduced an amendment that would prevent the Justice Department from using funds to prevent states “from implementing their own laws that […]

Pain Management & Mental Health Are the Leading ‘Why’ Behind Cannabis Buys

June 5th, 2019 - Ryan Allway

Over 80 percent of U.S. adults over 21 would consume cannabis to treat chronic pain, improve mental health, and treat minor injuries, according to a new Nielsen study. The study found that more than 40 percent of all headache/migraine, arthritic pain, and back/neck pain sufferers are interested in consuming cannabis. About 70 percent believe that […]

FDA’s First CBD Panel Yields a Lot of Uncertainty

June 4th, 2019 - Ryan Allway

The U.S. Food and Drug Commission (FDA) wrapped up its first ten-hour hearing on cannabidiol (CBD) last week. More than 100 witnesses urged the agency to pave the way for CBD foods and over-the-counter products, but many researchers argue that the substance hasn’t been well-studied and some companies have been making dangerous marketing claims. The […]

Illinois Becomes the First State to Legalize Cannabis Via Legislature

June 3rd, 2019 - Ryan Allway

Illinois may be the eleventh state to legalize adult-use cannabis, but it’s the first to approve sales through the state legislature rather than a ballot measure. Beginning on January 1, 2020, adults 21 and older will be able to purchase cannabis products in licensed stores and possess up to 30 grams of raw cannabis, 500 […]

Republicans Could Rally Behind Marijuana Banking Bill

May 30th, 2019 - Ryan Allway

Sen. Mike Crapo (R-ID), Chair of the Senate Banking Committee, could schedule legislation designed to increase access to the banking sector for a hearing if it passes the House of Representatives. Sens. Kevin Cramer (R-ND) and Rand Paul (R-KY) told Marijuana Moment that they discussed the legislation with Crapo and are hopeful that he will […]

These Bees Make Honey with Cannabis Resin

May 29th, 2019 - Ryan Allway

French beekeeper Nicolas Trainerbees (a nickname) is passionate about nature and has self-medicated with cannabis since a very early age. After training bees to collect sugar from fruits rather than flowers, he turned his attention toward the cannabis plant to merge his passions. In 2006, he began training bees to collect the resin from cannabis […]

Medical Marijuana in Maryland: What You Need to Know

May 28th, 2019 - Ryan Allway

Medical marijuana was legalized in Maryland in 2018 after years of debate in the General Assembly. Since then, the state has registered more than 17,000 patients, authorized more than 500 doctors, nurses, and dentists, and licensed more than 100 dispensaries located throughout the state. The state cannabis industry is regulated by the Maryland Medical Cannabis […]

FDA to Provide Much-Needed Guidance on CBD this Week

May 28th, 2019 - Ryan Allway

The U.S. Food and Drug Administration (FDA) will hold its first public hearing on how it will regulate cannabidiol (CBD) products this week. On May 31, the agency could provide much-needed guidance into the legal status of the cannabinoid and potentially introduce limits on how much of the substance can be included in foods and […]


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading